Secures over $30 Million in Oversubscribed Series F Financing

San Jose, Calif. July 18, 2023 VitalConnect\xae, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced closing on an oversubscribed Series F financing in excess of $30 million. The additional funding will support VitalConnects rapidly growing remote cardiac monitoring business while advancing key partnerships with the largest hospital systems in the United States to provide remote patient monitoring in an in-patient setting.VitalConnects services have been widely adopted at an accelerated pace over the past 24 months, enabling our revenue to triple from 2021 to 2022, and putting us on track to nearly double revenue again in 2023. We are also experiencing significant EBITDA improvement and we expect to achieve profitability in 2024, said Peter Van Haur, CEO of VitalConnect. We are committed to supporting the organization to enable them to maximize both revenue and profitability.Founded in 2011, VitalConnect has deployed hundreds of thousands of biosensors throughout the world, including leading healthcare facilities such as Brigham and Womens, Hackensack Medical Center, Northwell Health and John Radcliffe Hospital-Oxford University. VitalConnect leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms that achieve better health and economic outcomes.